Patents by Inventor Erwin Goldberg

Erwin Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic peptide producing antibodies of enhanced binding to human LDH-C.sub.4
    Patent number: 4990596
    Abstract: A synthetic peptide producing antibodies of enhanced binding to the human C.sub.4 isozyme of lactate dehydrogenase (LDH-C.sub.4) is composed of amino acids corresponding to the 9 to 20 sequence of the human enzyme. The peptide can be used as the active component of an antifertility vaccine for women.
    Type: Grant
    Filed: February 16, 1989
    Date of Patent: February 5, 1991
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Synthetic peptide compounds producing anitbodies binding to human LDH-C.sub .
    Patent number: 4782136
    Abstract: Synthetic peptide compounds are provided which are capable of producing antibodies binding to the lactate dehydrogenase enzyme of human serum (LDH-C.sub.4). The peptide compounds comprise antigenic sequences of human LDH-C.sub.4. The peptide compounds can be used to prepare vaccines for reducing the fertility of women.
    Type: Grant
    Filed: December 1, 1986
    Date of Patent: November 1, 1988
    Assignee: Northwestern University
    Inventors: Erwin Goldberg, Jose L. Millan
  • Antigenic peptide compounds
    Patent number: 4585587
    Abstract: The novel antigenic linear peptides of this invention comprise peptides of from 4 to 13 amino acids, which are characterized by containing the sequence valine-leucine-aspartic acid-methionine. These compounds correspond with the amino acids 231 to 243, or segments thereof including sequence 239-242 of mouse LDH-C.sub.4. The coupounds have utility in vaccines for reducing the fertility of female mammals.
    Type: Grant
    Filed: October 19, 1984
    Date of Patent: April 29, 1986
    Assignee: Northwestern University
    Inventors: Erwin Goldberg, Thomas E. Wheat
  • Antigenic peptide compound
    Patent number: 4578219
    Abstract: The novel antigenic linear peptide of this invention comprise a linear peptide of 13 amino acids, comprising the sequence Val-Asn-Met-Thr-Ala-Gly-Glu-Glu-Gly-Leu-Leu-Lys-Lys. This compound corresponds with the amino acids 304 to 316 of mouse LDH-C.sub.4. The compound has utility in vaccines for reducing the fertility of female mammals.
    Type: Grant
    Filed: October 19, 1984
    Date of Patent: March 25, 1986
    Assignee: Northwestern University
    Inventors: Erwin Goldberg, Thomas E. Wheat
  • Antigenic peptide compounds
    Patent number: 4392997
    Abstract: The novel antigenic peptide compounds of this invention comprise sequences of 12 to 19 amino acids, which include twelve amino acid sequence glutamic acid-glutamine-leucine-isoleucine-glutamine-asparagine-leucine-valine-prol ine-glutamic acid-aspartic acid-lysine, all of the amino acids being in their L-forms. The compounds have utility in vaccines for reducing the fertility of mammals.
    Type: Grant
    Filed: June 16, 1982
    Date of Patent: July 12, 1983
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Antigenic linear peptide compounds
    Patent number: 4377516
    Abstract: The novel antigenic linear peptide compounds of this invention comprise sequences of from 10 to 14 amino acids which include the sequence arginine-methionine-valine-serine-glycine-glutamine-threonine-arginine-leu cine-aspartic acid, all of the amino acids with the exception of glycine being in their L-forms. The compounds have utility in vaccines for reducing fertility of mammals.
    Type: Grant
    Filed: December 10, 1981
    Date of Patent: March 22, 1983
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Antigenic linear peptide compound
    Patent number: 4354967
    Abstract: The novel antigenic linear peptide compound of this invention comprises a sequence of ten amino acids namely, serine-leucine-asparagine-proline-alanine-isoleucine-glycine-threonine-asp artic acid-lysine, all of the amino acids being in their L-forms with the exception of glycine. The compound has utility in vaccines for reducing the fertility of mammals.
    Type: Grant
    Filed: June 26, 1981
    Date of Patent: October 19, 1982
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Antigenic linear peptide compounds
    Patent number: 4353822
    Abstract: The novel antigenic linear peptide compounds of this invention are characterized by providing a sequence of eight amino acids comprising isoleucine-serine-glycine-phenylalanine-proline-valine-glycine-arginine, all of the amino acids with the exception of glycine being in their L-forms. The isoleucine may comprise the N-terminal end or may be bonded to N-terminal glycine, and the arginine may be the C-terminal amino acid or may be bonded to C-terminal valine. The compounds have utility in vaccines for reducing the fertility of mammals.
    Type: Grant
    Filed: May 26, 1981
    Date of Patent: October 12, 1982
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Antigenic linear peptide compound
    Patent number: 4310456
    Abstract: The novel antigenic linear peptide compound of this invention comprises a sequence of nine amino acids; namely, arginine-methionine-valine-serine-glycine-glutaminethreonine-arginine-leuc ine, all of the amino acids with the exception of glycine being in their L-forms. The compound has utility in vaccines for reducing fertility of mammals.
    Type: Grant
    Filed: August 18, 1980
    Date of Patent: January 12, 1982
    Assignee: Northwestern University
    Inventor: Erwin Goldberg
  • Antigenic peptide compound
    Patent number: 4290944
    Abstract: The novel antigenic peptide compound of this invention comprises a sequence of seven amino acids, namely, methionine-glutamine-lysine-aspartic acid-leucine-glutamic acid-leucine, all of the amino acids being in their L-forms. The compound has utility in vaccines for reducing the fertility of mammals.
    Type: Grant
    Filed: July 31, 1980
    Date of Patent: September 22, 1981
    Assignee: Northwestern University
    Inventor: Erwin Goldberg